Keyphrases
Taiwan
83%
Metastatic Colorectal Cancer (mCRC)
61%
Chemotherapy
47%
5-fluorouracil (5-FU)
46%
Colorectal Carcinoma
42%
Non-Hodgkin Lymphoma
42%
Oxaliplatin
39%
Polymorphism
38%
Leucovorin
36%
Chronic Myeloid Leukemia
30%
Carcinoembryonic Antigen
29%
Colorectal Cancer Patients
29%
Carcinoembryonic Antigen Levels
28%
Prognostic Factors
25%
Bone Marrow Transplantation
25%
High Dose
25%
Salvage Therapy
25%
Diffuse Large B-cell Lymphoma (DLBCL)
24%
FOLFOX
24%
Thymosin
24%
Elderly Patients
23%
Overexpression
22%
Apoptosis
20%
Colorectal Cancer
20%
Colon Cancer Cells
19%
Confidence Interval
19%
Metastatic Breast Cancer
18%
General Hospital
18%
Complete Remission
17%
Multivariate Analysis
17%
Taipei
17%
Lymphoma Patients
16%
Allogeneic Bone Marrow Transplantation
16%
Graft-versus-host Disease (GvHD)
16%
Acute Myeloid Leukemia
15%
Independent Prognostic Factor
15%
Overall Survival
15%
Paclitaxel
15%
SW480
15%
Response Rate
15%
Hepatocellular Carcinoma Cells
14%
Lung Cancer
14%
Hematopoietic Stem Cell Transplantation
14%
Acute Promyelocytic Leukemia
14%
Mitoxantrone
14%
Phase II Study
14%
Hospice
14%
Asian Patients
14%
First-line Therapy
14%
NF-B
14%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Chemotherapy
56%
Fluorouracil
46%
Folinic Acid
46%
Oxaliplatin
43%
Metastatic Colorectal Cancer
41%
Nonhodgkin Lymphoma
34%
Carcinoembryonic Antigen
31%
Malignant Neoplasm
29%
Disease
25%
Remission
24%
Neoplasm
24%
Colon Carcinoma
23%
Thymosin
19%
Liver Cell Carcinoma
19%
Metastatic Breast Cancer
18%
Neuropathy
18%
Overall Survival
17%
Prevalence
17%
Lung Cancer
16%
Epidermal Growth Factor Receptor
15%
Paclitaxel
14%
Diffuse Large B Cell Lymphoma
14%
Mitoxantrone
14%
Regorafenib
14%
Progression Free Survival
13%
Oxaliplatin-Induced Neuropathy
12%
Cytarabine
12%
Combination Therapy
10%
Irinotecan
10%
Anthracycline
10%
Retrospective Study
9%
UFT
9%
Infection
9%
Dexamethasone
9%
Rituximab
9%
Metastasis Potential
9%
Mitogen Activated Protein Kinase
9%
Promyelocytic Leukemia
9%
Transitional Cell Carcinoma
9%
Interstitial Pneumonia
9%
Retinoic Acid
9%
Cetuximab
9%
Acute Pancreatitis
9%
Abdominal Cancer
9%
Breast Cancer
9%
Cisplatin
8%
Vasculotropin
8%
Chronic Myeloid Leukemia
8%
Carcinoma
8%
Medicine and Dentistry
Colorectal Carcinoma
39%
Chemotherapy
36%
Carcinoembryonic Antigen
29%
Prognostic Factor
28%
Elderly Patient
23%
Neoplasm
21%
Bone Marrow Transplantation
20%
Disease
19%
Chronic Myelogenous Leukemia
19%
Non-Hodgkin Lymphoma
18%
Metastatic Carcinoma
17%
Allogenic Bone Marrow Transplantation
17%
Malignant Neoplasm
17%
Colon Carcinoma
16%
Oxaliplatin
16%
Thymosin
14%
Transplantation
13%
Drug Megadose
11%
Prevalence
11%
Vincristine
11%
Folinic Acid
11%
Metastatic Colorectal Cancer
11%
Acute Myeloid Leukemia
10%
Carcinoma
10%
Diffuse Large B-Cell Lymphoma
10%
Neuropathy
10%
Proportional Hazards Model
9%
Langerhans Cell Histiocytosis
9%
Acute Promyelocytic Leukemia
9%
Transitional Cell Carcinoma
9%
Rituximab
9%
Hepatitis B
9%
Tretinoin
9%
Carcinoma Cell
9%
Adnexa
9%
FOLFOX
9%
Comparative Genomic Hybridization
9%
Lung Function
9%
Esophageal Squamous Cell Carcinoma
9%
MALT Lymphoma
9%
Univariate Analysis
9%
Multivariate Analysis
8%
Prednisolone
8%
Graft Versus Host Reaction
8%
Overall Survival
8%
Infection
7%
Doxorubicin
7%
Fluorouracil
7%
Hematopoietic Stem Cell Transplantation
7%
Chromosome Aberration
7%